Overview

Evaluation of Pirfenidone as a Novel Therapeutic Strategy Against Recurrent Acute Pancreatitis.

Status:
RECRUITING
Trial end date:
2028-09-01
Target enrollment:
Participant gender:
Summary
This clinical will evaluate the safety, tolerability and early efficacy of pirenidone in patients with recurrent acute pancreatitis.
Phase:
PHASE2
Details
Lead Sponsor:
University of Alabama at Birmingham
Collaborator:
Congressionally Directed Medical Research Programs
Treatments:
pirfenidone